Top

Published in:

Open Access 01-02-2017 | Pictorial Review

Imaging biomarkers of dementia: recommended visual rating scales with teaching cases

Published in: Insights into Imaging | Issue 1/2017

Abstract

The diagnostic work up of dementia may benefit from structured reporting of CT and/or MRI and the use of standardised visual rating scales. We advocate a more widespread use of standardised scales as part of the workflow in clinical and research evaluation of dementia. We propose routine clinical use of rating scales for medial temporal atrophy (MTA), global cortical atrophy (GCA) and white matter hyperintensities (WMH). These scales can be used for evaluation of both CT and MRI and are efficient in routine imaging assessment in dementia, and may improve the accuracy of diagnosis. Our review provides detailed imaging examples of rating increments in each of these scales and a separate teaching file. The radiologist should relate visual ratings to the clinical assessment and other biomarkers to assist the clinician in the diagnostic decision.

Teaching points

• Clinical dementia diagnostics would benefit from structured radiological reporting.

• Standardised rating scales should be used in dementia assessment.

• It is important to relate imaging findings to the clinically suspected diagnosis.

Available only for authorised users

Harper L, Fumagalli GG, Barkhof F et al (2016) MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases. Brain J Neurol. doi:10.1093/brain/aww005

Wahlund L-O, Westman E, Van Westen D et al (2013) Structural brain imaging may improve diagnostics in dementia. Lakartidningen 110:2116–2118PubMed

American Psychiatric Association, American Psychiatric Association, DSM-5 Task Force (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association, ArlingtonCrossRef

Glenner GG, Wong CW (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885–890CrossRefPubMed

Masters CL, Simms G, Weinman NA et al (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82:4245–4249CrossRefPubMedPubMedCentral

Goedert M, Spillantini MG, Crowther RA (1991) Tau proteins and neurofibrillary degeneration. Brain Pathol Zurich Switz 1:279–286CrossRef

Braak E, Griffing K, Arai K et al (1999) Neuropathology of Alzheimer’s disease: what is new since A. Alzheimer? Eur Arch Psychiatry Clin Neurosci 3:14–22CrossRef

Westman E, Simmons A, Muehlboeck J-S et al (2011) AddNeuroMed and ADNI: similar patterns of Alzheimer’s atrophy and automated MRI classification accuracy in Europe and North America. NeuroImage 58:818–828CrossRefPubMed

Henneman WJP, Sluimer JD, Barnes J et al (2009) Hippocampal atrophy rates in Alzheimer disease. Neurology 72:999–1007CrossRefPubMedPubMedCentral

10.

den Heijer T, van der Lijn F, Koudstaal PJ et al (2010) A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain J Neurol 133:1163–1172CrossRef

11.

Cordonnier C, van der Flier WM (2011) Brain microbleeds and Alzheimer’s disease: innocent observation or key player? Brain. doi:10.1093/brain/awq321 PubMed

12.

Pantoni L (2010) Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9:689–701CrossRefPubMed

13.

Wallin A, Nordlund A, Jonsson M et al (2015) The Gothenburg MCI study: design and distribution of Alzheimer’s disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. doi:10.1038/jcbfm.2015.147

14.

Society A ’s Demography. https://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=412. Accessed 24 Apr 2016

15.

Vann Jones SA, O’Brien JT (2014) The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med 44:673–683CrossRefPubMed

16.

Dubois B, Feldman HH, Jacova C et al (2014) Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 13:614–629CrossRefPubMed

17.

Frisoni GB, Fox NC, Jack CR et al (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6:67–77CrossRefPubMedPubMedCentral

18.

Burton EJ, Barber R, Mukaetova-Ladinska EB et al (2009) Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 132:195–203CrossRefPubMed

19.

Harper L, Barkhof F, Fox NC, Schott JM (2015) Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2014-310090

20.

Scheltens P, Launer LJ, Barkhof F et al (1995) Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol 242:557–560CrossRefPubMed

21.

Scheltens P, Leys D, Barkhof F et al (1992) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55:967–972CrossRefPubMedPubMedCentral

22.

Dubois B, Feldman HH, Jacova C et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746CrossRefPubMed

23.

Cavallin L, Bronge L, Zhang Y et al (1987) (2012) Comparison between visual assessment of MTA and hippocampal volumes in an elderly, non-demented population. Acta Radiol Stockh Swed 53:573–579

24.

Pereira JB, Cavallin L, Spulber G et al (2014) Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs. J Intern Med 275:317–330CrossRefPubMed

25.

Ferreira D, Cavallin L, Larsson E-M et al (2015) Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer’s disease and mild cognitive impairment. J Intern Med 278:277–290CrossRefPubMed

26.

Wattjes MP, Henneman WJP, van der Flier WM et al (2009) Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology 253:174–183CrossRefPubMed

27.

Westman E, Cavallin L, Muehlboeck J-S et al (2011) Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer’s disease. PLoS One 6:e22506CrossRefPubMedPubMedCentral

28.

Cavallin L, Løken K, Engedal K et al (1987) (2012) Overtime reliability of medial temporal lobe atrophy rating in a clinical setting. Acta Radiol Stockh Swed 53:318–323

29.

Pasquier F, Leys D, Weerts JG et al (1996) Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 36:268–272CrossRefPubMed

30.

Ferreira D, Cavallin L, Granberg T, et al. (2015) Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition. Eur Radiol 1–14. doi:10.1007/s00330-015-4101-9

31.

McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269CrossRefPubMedPubMedCentral

32.

Barkhof F, Fox NC, Bastos-Leite AJ, Scheltens P (2011) Neuroimaging in Dementia. Springer Berlin Heidelberg, BerlinCrossRef

33.

Wahlund LO, Barkhof F, Fazekas F et al (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke J Cereb Circ 32:1318–1322CrossRef

34.

Koedam ELGE, Lehmann M, van der Flier WM et al (2011) Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol 21:2618–2625CrossRefPubMedPubMedCentral

Title: Imaging biomarkers of dementia: recommended visual rating scales with teaching cases
Publication date: 01-02-2017
Published in: Insights into Imaging / Issue 1/2017
Electronic ISSN: 1869-4101
DOI: https://doi.org/10.1007/s13244-016-0521-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Imaging biomarkers of dementia: recommended visual rating scales with teaching cases

Abstract

Teaching points

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Teaching points

Please log in to get access to this content

Other articles of this Issue 1/2017

The craniocervical junction: embryology, anatomy, biomechanics and imaging in blunt trauma

Contrast opacification on thoracic CT angiography: challenges and solutions

Diverticulitis: a comprehensive review with usual and unusual complications

Imaging of patellar fractures

Summary of the proceedings of the international forum 2016: “Imaging referral guidelines and clinical decision support - how can radiologists implement imaging referral guidelines in clinical routine?”

Error and discrepancy in radiology: inevitable or avoidable?